357 related articles for article (PubMed ID: 30348199)
1. Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines.
Ravindranathan S; Nguyen KG; Kurtz SL; Frazier HN; Smith SG; Koppolu BP; Rajaram N; Zaharoff DA
Breast Cancer Res; 2018 Oct; 20(1):126. PubMed ID: 30348199
[TBL] [Abstract][Full Text] [Related]
2. Xuanhusuo powder has an anti-breast cancer effect by inhibiting myeloid-derived suppressor cell differentiation in the spleen of mice through down-regulating granulocyte colony stimulating factor.
Mao Y; Liu X; He K; Lin C; He B; Gao J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 52(1):88-100. PubMed ID: 37283122
[TBL] [Abstract][Full Text] [Related]
3. Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.
Abe H; Wada H; Baghdadi M; Nakanishi S; Usui Y; Tsuchikawa T; Shichinohe T; Hirano S; Seino K
Hum Cell; 2016 Apr; 29(2):58-66. PubMed ID: 26857856
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.
Dols A; Smith JW; Meijer SL; Fox BA; Hu HM; Walker E; Rosenheim S; Moudgil T; Doran T; Wood W; Seligman M; Alvord WG; Schoof D; Urba WJ
Hum Gene Ther; 2003 Jul; 14(11):1117-23. PubMed ID: 12885350
[TBL] [Abstract][Full Text] [Related]
5. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
7. Current status of autologous breast tumor cell-based vaccines.
Kurtz SL; Ravindranathan S; Zaharoff DA
Expert Rev Vaccines; 2014 Dec; 13(12):1439-45. PubMed ID: 25308888
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.
Yoshimura T; Nakamura K; Li C; Fujisawa M; Shiina T; Imamura M; Li T; Mukaida N; Matsukawa A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888216
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
[TBL] [Abstract][Full Text] [Related]
10. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model.
Lin CC; Tsai CC; Lee JM; Fang CH; Chang KS; Wong KK; Lin CT; Qiu JT
Vaccine; 2016 Jan; 34(1):134-41. PubMed ID: 26546261
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine.
Huang X; Ye D; Thorpe PE
Vaccine; 2011 Jun; 29(29-30):4785-93. PubMed ID: 21557977
[TBL] [Abstract][Full Text] [Related]
13. EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.
Jing X; Sonoki T; Miyajima M; Sawada T; Terada N; Takemura S; Sakaguchi K
Cancer Med; 2016 Jun; 5(6):1214-27. PubMed ID: 26923183
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor vaccine expressing Granulocyte-Macrophage Colony Stimulating Factor and interleukin-18 fusion on cancer cells and its possible application for cancer immunotherapy.
Lee SR; Park YK; Shin BA; Park HR
Cytokine; 2017 Jan; 89():143-154. PubMed ID: 26868088
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.
Thomas MC; Greten TF; Pardoll DM; Jaffee EM
Hum Gene Ther; 1998 Apr; 9(6):835-43. PubMed ID: 9581906
[TBL] [Abstract][Full Text] [Related]
16. rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.
Ye J; Wang H; Medina R; Chakraborty S; Sun M; Valenzuela A; Sang X; Zhang Y; Uher O; Zenka J; Pacak K; Zhuang Z
J Exp Clin Cancer Res; 2023 Jul; 42(1):163. PubMed ID: 37434263
[TBL] [Abstract][Full Text] [Related]
17. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
Rosenbaum P; Artaud C; Bay S; Ganneau C; Campone M; Delaloge S; Gourmelon C; Loirat D; Medioni J; Pein F; Sablin MP; Tredan O; Varga A; Leclerc C
Cancer Immunol Immunother; 2020 May; 69(5):703-716. PubMed ID: 32034426
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity.
Sakamoto C; Kohara H; Inoue H; Narusawa M; Ogawa Y; Hirose-Yotsuya L; Miyamoto S; Matsumura Y; Yamada K; Takahashi A; Tani K
Cancer Gene Ther; 2017 Apr; 24(4):165-174. PubMed ID: 28084317
[TBL] [Abstract][Full Text] [Related]
19. A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model.
Soliman H; Mediavilla-Varela M; Antonia SJ
Breast Cancer (Dove Med Press); 2015; 7():389-97. PubMed ID: 26719725
[TBL] [Abstract][Full Text] [Related]
20. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
Front Immunol; 2018; 9():776. PubMed ID: 29867922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
